Track insider transactions across markets
| 30 days | 90 days | 120 days | |
|---|---|---|---|
| Average return | -0% | 8.2% | 15.1% |
| Success rate | 53% | 68% | 82% |
| Transactions |
6
83% Buy
|
34
71% Buy
|
47
69% Buy
|
| Position | Company | Period |
|---|---|---|
| Chief Executive Officer | InDex Pharmaceuticals Holding AB | Jan. 1, 2016 - |
| President, Chief Executive Officer | Diamyd Medical AB | Jan. 1, 2013 - March 1, 2015 |
Search
| Notification date | Transaction date | Company | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2019-10-09 | 2019-10-08 |
|
B Purchase |
20,130
117.77
SEK853,157 |
20,130 | 117.77 | SEK853,157 | |
| 2019-09-20 | 2019-09-20 |
|
B Purchase |
48,176
102.55
SEK2,871,813 |
48,176 | 102.55 | SEK2,871,813 | |
| 2017-07-06 | 2017-07-04 |
|
B Purchase |
71,505
345.02
SEK551,382 |
71,505 | 345.02 | SEK551,382 | |
| 2017-03-26 | 2017-03-24 |
|
B Purchase |
5,000
5.31
SEK26,550 |
5,000 | 5.31 | SEK26,550 | |
| 2016-11-23 | 2016-11-22 |
|
B Purchase |
23,809
5.85
SEK139,283 |
23,809 | 5.85 | SEK139,283 | |
| 2016-11-23 | 2016-11-22 |
|
S Sale |
23,809
5.85
SEK139,283 |
23,809 | 5.85 | SEK139,283 | |
| 2016-10-11 | 2016-10-10 |
|
B Purchase |
23,809
8.40
SEK199,996 |
23,809 | 8.40 | SEK199,996 |